Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720

Clinical and Experimental Immunology

Volumn 123, Issue 2, 2001, Pages 331-339

  Li, X K ^a   Tamura, A ^a   Fujino, M ^a   Guo, L ^a   Kakefuda, T ^a   Funeshima, N ^a   Enosawa, S ^a   Amari, M ^a,b   Naoe, S ^a,b   Amemiya, H ^a   Suzuki, S ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allograft; Apoptosis; FTY720; Lymphocyte; Ongoing rejection

Indexed keywords

FINGOLIMOD; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2; MESSENGER RNA; PERFORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INDUCED DISEASE; DRUG MECHANISM; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; LYMPHOCYTES; PROPYLENE GLYCOLS; RATS; RATS, INBRED LEW; SPHINGOSINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035114740     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01434.x     Document Type: Article

References (33)

1. Simple compounds, 2-alkyl-2-amino-1,3-propanediols, have potent immunosuppressive activity
2. Molecular mechanism of immunosuppressive agents
3. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing
4. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo
5. FTY720, a novel immunosuppressive agent, enhances upregulation of the cell adhesion molecular ICAM-1 in TNF-alpha treated human umbilical vein endothelial cells
6. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation
7. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720
8. Reversal of transplantation immunity by liver grafting
9. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase
10. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression
11. Quantitative or semi-quantitative PCR: Reality versus myth
12. A simple quantitative measurement of mRNA of human β-actin by reverse transcription competitive PCR with a compact digital camera
13. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
14. Deoxyspergualin. Mode of action and clinical trials
15. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
16. Induction of lymphocyte apoptosis by a novel immunosuppressant FTY720: Relation with Fas, Bcl-2 and Bax expression
17. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes
18. The in vivo induction of lymphocyte apoptosis in MRL-Ipr/Ipr mice treated with FTY720
19. Bcl-2 and the regulation of programmed cell death
20. Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerates programmed cell death
21. Caspase requirement for the apoptotic death of WR19L-induced by FTY720
22. Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation
23. Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway
24. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies
25. Activation of Fas and perforin pathways in rat liver allograft rejection
26. Acute liver allograft rejection in the rat. An analysis of the immune response
27. Spontaneous acceptance of liver allografts in the rat. Analysis of the immune response
28. Apoptosis as a mechanism of cell death in liver allograft rejection
29. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction
30. Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid
31. FTY720 inhibits the mRNA expression of intragraft cytotoxic molecules, leading to cardiac allograft survival
32. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats